Knight Therapeutics Income Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	510.45	450.09	371.3	328.2	293.56	243.48
Revenue Growth (YoY)	36.93%	21.22%	13.13%	11.80%	20.57%	22.03%
Cost of Revenue	275.98	249.86	196.9	175.55	155.5	128.07
Gross Profit	234.47	200.23	174.41	152.65	138.06	115.41
Selling, General & Admin	132.41	124.11	99.35	83.69	88.62	74.38
Depreciation & Amortization Expenses	54.69	49.49	44.36	45.04	51.74	41.18
Research & Development	33.61	28.98	23.3	17.55	14.76	12.69
Other Operating Expenses	-	-	-	9.26	23.98	-
Total Operating Expenses	220.71	202.58	167.01	155.54	179.11	128.24
Operating Income	13.77	-2.35	7.4	-2.89	-41.04	-12.83
Interest Income	5.3	6.21	10.41	12.58	10.63	7.38
Interest Expense	-11.31	-10.42	-9.22	-12.49	-6.6	-3.62
Other Non-Operating Income (Expense)	0.12	-0.14	-6.53	-19.19	-6.95	15.76
Total Non-Operating Income (Expense)	-5.89	-4.35	-5.35	-19.1	-2.92	19.52
Pretax Income	7.88	-6.7	2.05	-21.99	-43.96	6.69
Provision for Income Taxes	0.14	0	0	0	0	0
Net Income	5.61	-5.37	4.33	-16.84	-29.89	-15.68
Net Income to Common	5.61	-5.37	4.33	-16.84	-29.89	-15.68
Net Income Growth	-49.29%	-	-	-	-	-
Shares Outstanding (Basic)	99	100	101	107	115	124
Shares Outstanding (Diluted)	100	100	101	107	115	125
Shares Change (YoY)	-1.34%	-1.84%	-5.61%	-6.46%	-7.74%	-5.65%
EPS (Basic)	0.05	-0.05	0.04	-0.16	-0.26	0.13
EPS (Diluted)	0.05	-0.05	0.04	-0.16	-0.26	0.13
EPS Growth	-54.89%	-	-	-	-	-59.38%
Shares Outstanding	98.25	99.18	100.03	101.17	112.21	117.78
Free Cash Flow	101.12	67.05	33.81	34.99	42.12	40.79
Free Cash Flow Growth	50.81%	98.30%	-3.37%	-16.92%	3.26%	-
Free Cash Flow Per Share	1.02	0.67	0.33	0.33	0.37	0.33
Gross Margin	45.93%	44.49%	46.97%	46.51%	47.03%	47.40%
Operating Margin	2.70%	-0.52%	1.99%	-0.88%	-13.98%	-5.27%
Profit Margin	1.10%	-1.19%	1.17%	-5.13%	-10.18%	-6.44%
FCF Margin	19.81%	14.90%	9.11%	10.66%	14.35%	16.75%
EBITDA	74.94	54.22	60.51	47.51	21.58	35.08
EBITDA Margin	14.68%	12.05%	16.30%	14.48%	7.35%	14.41%
EBIT	13.77	-2.35	7.4	-2.89	-41.04	-12.83
EBIT Margin	2.70%	-0.52%	1.99%	-0.88%	-13.98%	-5.27%
Effective Tax Rate	1.80%	0.00%	0.00%	0.00%	0.00%	0.00%

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.